Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
89%(8 trials)

Phase Distribution

Ph phase_2
2
15%
Ph phase_3
3
23%
Ph phase_4
7
54%
Ph not_applicable
1
8%

Phase Distribution

0

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
7(53.8%)
N/ANon-phased studies
1(7.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(9)
Terminated(2)
Other(2)

Detailed Status

Completed9
unknown2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (15.4%)
Phase 33 (23.1%)
Phase 47 (53.8%)
N/A1 (7.7%)

Trials by Status

unknown215%
withdrawn215%
completed969%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13